Ghent University Academic Bibliography

Advanced

A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer

T Meyer, ME Caplin, DH Palmer, JW Valle, M Larvin, JS Waters, F Coxon, I Borbath, Marc Peeters UGent, E Nagano, et al. (2010) EUROPEAN JOURNAL OF CANCER. 46(3). p.526-533
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
III TRIAL, THERAPY, Gemcitabine, CCK2, Gastrin, Pancreas, Cancer, GROWTH
journal title
EUROPEAN JOURNAL OF CANCER
Eur. J. Cancer
volume
46
issue
3
pages
526 - 533
Web of Science type
Article
Web of Science id
000275594400021
JCR category
ONCOLOGY
JCR impact factor
4.944 (2010)
JCR rank
31/181 (2010)
JCR quartile
1 (2010)
ISSN
0959-8049
DOI
10.1016/j.ejca.2009.11.004
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1193776
handle
http://hdl.handle.net/1854/LU-1193776
date created
2011-03-22 11:02:32
date last changed
2016-12-19 15:45:50
@article{1193776,
  author       = {Meyer, T and Caplin, ME and Palmer, DH and Valle, JW and Larvin, M and Waters, JS and Coxon, F and Borbath, I and Peeters, Marc and Nagano, E and Kato, H},
  issn         = {0959-8049},
  journal      = {EUROPEAN JOURNAL OF CANCER},
  keyword      = {III TRIAL,THERAPY,Gemcitabine,CCK2,Gastrin,Pancreas,Cancer,GROWTH},
  language     = {eng},
  number       = {3},
  pages        = {526--533},
  title        = {A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer},
  url          = {http://dx.doi.org/10.1016/j.ejca.2009.11.004},
  volume       = {46},
  year         = {2010},
}

Chicago
Meyer, T, ME Caplin, DH Palmer, JW Valle, M Larvin, JS Waters, F Coxon, et al. 2010. “A Phase Ib/IIa Trial to Evaluate the CCK2 Receptor Antagonist Z-360 in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.” European Journal of Cancer 46 (3): 526–533.
APA
Meyer, T, Caplin, M., Palmer, D., Valle, J., Larvin, M., Waters, J., Coxon, F., et al. (2010). A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. EUROPEAN JOURNAL OF CANCER, 46(3), 526–533.
Vancouver
1.
Meyer T, Caplin M, Palmer D, Valle J, Larvin M, Waters J, et al. A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. EUROPEAN JOURNAL OF CANCER. 2010;46(3):526–33.
MLA
Meyer, T, ME Caplin, DH Palmer, et al. “A Phase Ib/IIa Trial to Evaluate the CCK2 Receptor Antagonist Z-360 in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.” EUROPEAN JOURNAL OF CANCER 46.3 (2010): 526–533. Print.